Albemarle Posts $0.53 Q4 Loss, Beats Revenue Forecast by 5.8%
The company posted a Q4 loss of $0.53 per share versus an expected loss of $0.40, missing EPS estimates by 33%. It generated revenues of $1.43 billion, beating consensus by 5.8% and marking a 16% year-over-year increase.
1. Q4 Earnings Details
Albemarle recorded a fourth-quarter adjusted loss of $0.53 per share, missing the projected loss of $0.40 and widening from a $0.19 loss in the prior quarter. This represented a 33% negative earnings surprise and followed three of the last four quarters in which the company topped consensus EPS estimates.
2. Revenue Performance
Sales rose to $1.43 billion in Q4, exceeding the $1.35 billion consensus by 5.8% and growing from $1.23 billion a year earlier. The revenue beat underscores strength across lithium products despite broader market volatility.
3. Stock Movement and Industry Context
Albemarle shares have climbed roughly 19.2% year-to-date, outpacing the S&P 500’s 1.4% gain, driven by robust demand in energy storage and electric vehicle markets. The company competes in the diversified chemicals industry, which remains challenged by cyclical headwinds.
4. Outlook and Consensus Estimates
Analysts forecast next quarter EPS of $0.11 on $1.18 billion in revenue, with full-year estimates at $4.34 per share on $5.45 billion in sales. Future stock performance will hinge on management commentary and revisions to earnings expectations.